Sanara MedTech stock reports 9 percent revenue growth
Published on 09/24/2026 at 23:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanara MedTech stock reported second-quarter 2026 revenue of USD 28.1 million, up 9 percent from USD 25.8 million a year earlier, while its Nasdaq quote stood at USD 35.10 on September 24, 2026. Stock Titan reported that soft tissue repair product sales rose 11 percent during the quarter.
Revenue grows but misses estimates
The revenue increase shows continued expansion in Sanara MedTech's wound-care business, but the quarterly result also carried a diluted loss of USD 0.05 per share. According to MarketBeat, revenue of USD 28.14 million missed the USD 28.95 million consensus estimate, while the loss per share was USD 0.03 below the forecast.
That combination matters for valuation: sales are growing, yet earnings conversion remains negative. The latest quarter delivered operating profit of USD 1.78 million and an operating margin of 6 percent, while net income was negative at USD 411,144.
Transaction terms set the reference point
The proposed sale to MiMedx gives investors a concrete valuation reference. Business Wire reported that shareholders would receive USD 33.00 in cash and 0.4735 MiMedx shares for each Sanara share.
The structure means the final value depends partly on MiMedx's share price, rather than on a fixed cash payment alone. A separate investor investigation cited by Business Wire has therefore placed attention on the adequacy of the consideration and the process behind the proposed transaction.
Stock stays near its yearly high
Sanara MedTech stock was trading at USD 35.10 on Nasdaq on September 24, 2026, down 0.14 percent from the previous close of USD 35.15. The price was 0.68 percent below the 52-week high of USD 35.34 and the company had a market capitalization of USD 322,676,406.
Sanara MedTech market and company data
- Company: Sanara MedTech Inc.
- Ticker: SMTI
- Trading venue: Nasdaq Capital Market
- Price as of September 24, 2026, 4:00 p.m. ET: USD 35.10
- Market capitalization: USD 322,676,406 as of September 24, 2026
- 52-week range: USD 16.05-35.34 as of September 24, 2026
- Sector / Industry: Health Care Equipment / Medical Devices
- Index membership: Russell 2000
